Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04799392 · ClinicalTrials.gov registry record · NA
NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons
A NA study, sponsored by NOWDiagnostics.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04799392 is a NA study that was terminated before completion, run by NOWDiagnostics. The registered enrollment target is 50 participants.
The verdict
NCT04799392, a NA study, was terminated before completion, sponsored by NOWDiagnostics.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently marketed device. The NOWDx COVID-19 Test is an in vitro lateral flow immunoassay intended for qualitative detection of total antibodies to SARS-CoV-2 in human fingerstick whole blood at the Point of Care (POC); i.e. in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation; and at home.
Interventions
- DEVICE NOWDx COVID-19 Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2021-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04799392
The ClinicalTrials.gov registry entry for NCT04799392 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NOWDiagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NOWDx COVID-19 Test is the first listed.
NCT04799392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04799392 about?
NCT04799392 is a clinical study titled "NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons". This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently marketed device. The NOWDx COVID-19 Test is an in vitro lateral flow immunoassay intended for qualitat...
What is the current status of trial NCT04799392?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2021-04-01. Estimated completion is 2021-10-28.
What interventions are being tested in trial NCT04799392?
The interventions under investigation include: NOWDx COVID-19 Test (DEVICE).
Who is sponsoring clinical trial NCT04799392?
This trial is sponsored by NOWDiagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.